3 Comments
User's avatar
Andrii Buvailo's avatar

Thanks, interesting post, but Schrodinger and Abcellear have pipelines, so they are not "just" service companies, certainly. Also, Cyclica was acquired a couple years ago by Recursion.

Expand full comment
Saurabh Mishra's avatar

Great post, But what would you consider a fund raising strategy for a biologics platform company ( platform already running) that needs just 7-10 M for setting up labs, and another 10-14 M for optimising say 2-3 candidates. The problem is that you need at least 24 M to come out with a product, How would you approach investors asking for a 24 M at one go, or asking 7-10 to set up labs etc. Any thoughts?

Expand full comment